Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: A prospective, randomized studyMarion Haubitz, R. Brunkhorst, D. Schaumann et al.|Arthritis & Rheumatism|1998Cited by 261
Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody‐associated vasculitis and renal involvement: A prospective, randomized studyMarion Haubitz, R. Brunkhorst, Hans-Joachim Schurek et al.|Arthritis & Rheumatism|1998Cited by 21
Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipientsVolker Kliem, R. Brunkhorst, D. Schaumann et al.|Transplantation Proceedings|1997Cited by 5
Tacrolimus for Steroid- and OKT3-Resistant Rejection in Kidney RecipientsVolker Kliem, R. Brunkhorst, Ruth Petersen et al.|Transplantation Proceedings|1998Cited by 5
Longterm Benefit of Additional Azathioprine in Cyclosporin/Prednisolone-Treated Patients with Chronic Renal Allograft DysfunctionVolker Kliem, R. Brunkhorst, K. M. Koch et al.|Unknown|1997Cited by 0